Your browser doesn't support javascript.
loading
Identification of lysosome-targeting drugs with anti-inflammatory activity as potential invasion inhibitors of treatment resistant HER2 positive cancers.
Hansen, Malene Bredahl; Postol, Maria; Tvingsholm, Siri; Nielsen, Inger Ødum; Dietrich, Tiina Naumanen; Puustinen, Pietri; Maeda, Kenji; Dinant, Christoffel; Strauss, Robert; Egan, David; Jäättelä, Marja; Kallunki, Tuula.
Afiliação
  • Hansen MB; Cell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.
  • Postol M; Cell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.
  • Tvingsholm S; Cell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.
  • Nielsen IØ; Cell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.
  • Dietrich TN; Cell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.
  • Puustinen P; Cell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.
  • Maeda K; Cell Death and Metabolism, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.
  • Dinant C; Genome Integrity Group, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.
  • Strauss R; Core Facility for Bioimaging, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.
  • Egan D; Genome Integrity Group, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Strandboulevarden 49, 2100, Copenhagen, Denmark.
  • Jäättelä M; Department of Cell Biology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands.
  • Kallunki T; Core Life Analytics, Padualaan, 83584 CH, Utrecht, The Netherlands.
Cell Oncol (Dordr) ; 44(4): 805-820, 2021 Aug.
Article em En | MEDLINE | ID: mdl-33939112
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos / Ensaios Antitumorais Modelo de Xenoenxerto / Lisossomos / Anti-Inflamatórios Tipo de estudo: Diagnostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cell Oncol (Dordr) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos / Ensaios Antitumorais Modelo de Xenoenxerto / Lisossomos / Anti-Inflamatórios Tipo de estudo: Diagnostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cell Oncol (Dordr) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Holanda